SQY Therapeutics, a biotechnology company based in Saint-Quentin-en-Yvelines, France, designs and produces antisense oligonucleotides of the tricyclo-DNA class. Objective: to implement R&D programs for genetic diseases, in particular neuromuscular diseases such as Duchenne Muscular Dystrophy.
Company Details
- Employees
- 21
- Founded
- -
- Address
- 2, Avenue De La Source De La Bièvre, Montigny-Le-Bretonneux,île-De-France 78180,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://sqy-therapeutics.com/
- HQ
- Montigny-le-Bretonneux, Île-de-France
Sqy Therapeutics Questions
Sqy Therapeutics's website is https://sqy-therapeutics.com/
Sqy Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/sqy-therapeutics
Sqy Therapeutics has
21 employees.
View email and phone details for 21
employees at Sqy Therapeutics.
Sqy Therapeutics's industry is
Biotechnology Research
Sqy Therapeutics's top competitors are
Onxeo,
Ose Immunotherapeutics,
Institut De Myologie,
Pharnext,
Abivax,
Genethon,
Atamyo Therapeutics,
Eurobio Scientific Fr,
Nanobiotix,
Neovacs.
Sqy Therapeutics's categories are Biotechnology Research
Sqy Therapeutics's founding year is 2015
